Inventor
IMBERT THIERRY
FR25 patents
⚠️ This page may combine multiple inventors who share the name “IMBERT THIERRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PF MEDICAMENT
13 patentsUS7456192B2Nov 25, 2008
3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof
PF MEDICAMENT9 citations82
US6107284AAug 22, 2000
Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments
PF MEDICAMENT16 citations82
US6008382ADec 28, 1999
Method for preparing 4'-Demethylepipodophyllotoxin from podophyllotoxin
PF MEDICAMENT8 citations73
US5948806ASep 7, 1999
Treatment of Parkinson's disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan)
PF MEDICAMENT9 citations72
US5661172AAug 26, 1997
Use of efaroxan and derivatives thereof for the treatment of Alzheimer's disease
PF MEDICAMENT7 citations72
US7846926B2Dec 7, 2010
(Poly)aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents
PF MEDICAMENT5 citations71
US5958945ASep 28, 1999
Naphthamide derivatives of 3-beta-amino azabicyclo octane or nonane as neuroleptic agents
PF MEDICAMENT13 citations71
US5880296AMar 9, 1999
Method for preparing an optically pure benzofuran carboxylic acid and use thereof for preparing efaroxan
PF MEDICAMENT10 citations71
US6610725B1Aug 26, 2003
Fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
PF MEDICAMENT7 citations68
US5643885AJul 1, 1997
Etoposide derivatives, process for preparing them, their use as a medicinal product and their use for the preparation of a medicinal product intended for anti-cancer treatment
PF MEDICAMENT4 citations62
US7932406B2Apr 26, 2011
Method for preparing 4β-amino-4′-demethyl-4-desoxypodophyllotoxin
PF MEDICAMENT2 citations59
US6153638ANov 28, 2000
Use of efaroxan for producing medicine for treating huntington 's disease
PF MEDICAMENT2 citations57
US9403840B2Aug 2, 2016
(Poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents
PF MEDICAMENT0 citations50
GUMINSKI YVES
4 patentsUS8193379B2Jun 5, 2012
Method for preparing 4B-amino-4′-demethyl-4-desoxypodophyllotoxin
GUMINSKI YVES1 citations47
US8148552B2Apr 3, 2012
Process for the synthesis of anticancer (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin
GUMINSKI YVES0 citations47
US8664409B2Mar 4, 2014
Process for the preparation of (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin useful for their applications in therapeutics as anticancer agent
GUMINSKI YVES0 citations36
US9439982B2Sep 13, 2016
Fluorescent cyanine-polyamine derivatives as a diagnostic probe
GUMINSKI YVES0 citations28
IMBERT THIERRY
3 patentsUS9216989B2Dec 22, 2015
(Poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents
IMBERT THIERRY0 citations47
US8492567B2Jul 23, 2013
(Poly)Aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents
IMBERT THIERRY0 citations47
US8288567B2Oct 16, 2012
(Poly) aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents
IMBERT THIERRY0 citations47